Seven Eight Capital’s Diebold Nixdorf Incorporated DBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-22,700
Closed -$371K 574
2017
Q4
$371K Buy
+22,700
New +$439K 0.04% 359
2016
Q4
Sell
-11,400
Closed -$283K 664
2016
Q3
$283K Buy
+11,400
New +$303K 0.08% 277
2014
Q2
Sell
-14,400
Closed -$574K 609
2014
Q1
$574K Sell
14,400
-5,565
-28% -$200K 0.5% 57
2013
Q4
$659K Buy
+19,965
New +$623K 0.73% 20

Other funds holding DBD

Seven Eight Capital's DBD Position: Q1 2018 in Review

Seven Eight Capital sold out of Diebold Nixdorf Incorporated (DBD) in Q1 2018, closing a stake of 22,700 shares — an estimated $371K sold.

Seven Eight Capital first reported a position in DBD in Q4 2013 and held it in 4 quarters. The position peaked at $659K in Q4 2013. 246 funds tracked by Wall St. Rank hold DBD as of Q1 2018.

  • Seven Eight Capital reported no remaining Diebold Nixdorf Incorporated position as of Q1 2018 after selling out during the quarter.
  • Seven Eight Capital sold 22,700 Diebold Nixdorf Incorporated shares in Q1 2018, an estimated $371K.
  • Seven Eight Capital first reported a position in Diebold Nixdorf Incorporated in Q4 2013 and held it in 4 quarters.
  • Seven Eight Capital's Diebold Nixdorf Incorporated position peaked at $659K in Q4 2013.
  • 246 funds tracked by Wall St. Rank held Diebold Nixdorf Incorporated as of Q1 2018.

Based on Seven Eight Capital's 13F filing for Q1 2018, filed 14 May 2018.